Valery L Payen
Overview
Explore the profile of Valery L Payen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
1422
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gratpain V, Loriot A, Bottemanne P, dAuria L, Terrasi R, Payen V, et al.
Heliyon
. 2024 Mar;
10(5):e27025.
PMID: 38463764
Neuro-inflammation occurs in numerous disorders such as multiple sclerosis, Alzheimer's disease and Parkinson's disease. However, anti-inflammatory drugs for the central nervous system have failed to show significant improvement when compared...
2.
Capeloa T, Krzystyniak J, dHose D, Canas Rodriguez A, Payen V, Zampieri L, et al.
Cancers (Basel)
. 2022 Mar;
14(6).
PMID: 35326667
To successfully generate distant metastases, metastatic progenitor cells must simultaneously possess mesenchymal characteristics, resist to anoïkis, migrate and invade directionally, resist to redox and shear stresses in the systemic circulation,...
3.
Capeloa T, Krzystyniak J, Canas Rodriguez A, Payen V, Zampieri L, Pranzini E, et al.
Cancers (Basel)
. 2022 Mar;
14(6).
PMID: 35326639
In oncology, the occurrence of distant metastases often marks the transition from curative to palliative care. Such outcome is highly predictable for breast cancer patients, even if tumors are detected...
4.
Payen V, Lavergne A, Alevra Sarika N, Colonval M, Karim L, Deckers M, et al.
JHEP Rep
. 2021 May;
3(3):100278.
PMID: 34027339
Background & Aims: The multiple vital functions of the human liver are performed by highly specialised parenchymal and non-parenchymal cells organised in complex collaborative sinusoidal units. Although crucial for homeostasis,...
5.
Contino S, Suelves N, Vrancx C, Vadukul D, Payen V, Stanga S, et al.
Front Neurosci
. 2021 Feb;
14:586108.
PMID: 33551720
Presenilin 1 (PS1) and Presenilin 2 (PS2) are predominantly known as the catalytic subunits of the γ-secretase complex that generates the amyloid-β (Aβ) peptide, the major constituent of the senile...
6.
Alevra Sarika N, Payen V, Fleron M, Ravau J, Brusa D, Najimi M, et al.
Cells
. 2020 Jun;
9(6).
PMID: 32486126
The lack of robust methods to preserve, purify and in vitro maintain the phenotype of the human liver's highly specialized parenchymal and non-parenchymal cell types importantly hampers their exploitation for...
7.
Payen V, Mina E, Van Hee V, Porporato P, Sonveaux P
Mol Metab
. 2019 Aug;
33:48-66.
PMID: 31395464
Background: Tumors are highly plastic metabolic entities composed of cancer and host cells that can adopt different metabolic phenotypes. For energy production, cancer cells may use 4 main fuels that...
8.
Milosevic T, Vertenoeil G, Payen V, Sonveaux P, Tulkens P, Constantinescu S, et al.
Int J Antimicrob Agents
. 2019 Aug;
54(5):661-667.
PMID: 31374333
Thrombocytopenia is commonly seen in patients receiving linezolid for >14 days. Linezolid is a reversible inhibitor of mitochondrial function in various cell types. This study investigated the inhibitory effects of...
9.
Payen V, Zampieri L, Porporato P, Sonveaux P
Cancer Metastasis Rev
. 2019 Mar;
38(1-2):189-203.
PMID: 30820778
In cancer, mitochondrial functions are commonly altered. Directly involved in metabolic reprogramming, mitochondrial plasticity confers to cancer cells a high degree of adaptability to a wide range of stresses and...
10.
Chereddy K, Payen V, Preat V
J Control Release
. 2018 Sep;
289:10-13.
PMID: 30244137
Poly(lactic-co-glycolic acid) (PLGA) is well known for its biocompatibility and minimal toxicity. It is one of the most promising biodegradable polymeric drug delivery systems able to get endorsement from regulatory...